YiChang HEC ChangJiang Pharmaceutical Co. Ltd Financials

Market Capitalization HK$8.25 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	4.71
Forward PE	3.58
Price to Sales TTM	HK$1.49
Price to Book MRQ	HK$0.95
Enterprise to Revenue	1.66
Enterprise to EBITDA	3.65

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	29.74%
Operating Margin	33.33%
Return on Assets TTM	10.30%
Return on Equity TTM	19.25%

Income Statement

Revenue TTM	HK$5,946,130,768
Revenue per Share TTM	HK$6.30
Quarterly Revenue Growth	-23.50%
Gross Profit TTM	HK$4,691,204,317
EBITDA	HK$3,295,851,000
Net Income to Common TTM	HK$1,768,552,527
Diluted EPS TTM	HK$1.99
Quarterly Earnings Growth YoY	-33.50%

Balance Sheet

Total Cash MRQ	HK$1,634,676,355
Total Cash per Share MRQ	HK$1.73
Total Debt MRQ	HK$
Total Debt to Equity MRQ	27.00
Current Ratio MRQ	2.15
Book Value per Share MRQ	HK$9.85

Cash Flow

Operating Cash Flow TTM	HK$485,983,278
Levered Free Cash Flow TTM	HK$-707,368,547

1558 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	653,768,000
Float Shares	405,321,922
Avg 10 Volume	2,239,296
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	38.00%
% Held by Institutions	5.20%

Stock Price Summary

Beta	0.09
Fifty Two Week Low	HK$7.91
Fifty Two Week High	HK$13.30
Fifty Two Week Change	5.25%
Day 50 MA	HK$9.58
Day 200 MA	HK$9.78

Dividends and Splits

Forward Annual Dividend Rate	HK$0.23
Forward Annual Dividend Yield	2.48%
Trailing Annual Dividend Rate	HK$0.28
Trailing Annual Dividend Yield	3.03%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2020-09-29
Last Split Factor
Last Split Date	2020-06-09